Combinations of an Acetyl CoA Carboxylase Inhibitor with Hepatic Lipid Modulating Agents Do Not Augment Antifibrotic Efficacy in Preclinical Models of NASH and Fibrosis
Hepatology Communications（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined